Ex-Retrophin CEO Gave Away Stock, Investor Suit Says
The former CEO of biopharmaceutical company Retrophin Inc. handed out stock without shareholder approval and misrepresented the company's finances, according to a recent securities class action filed in New York federal court. ...To view the full article, register now.
Already a subscriber? Click here to view full article